Dinner, Shira
Dunn, Tamara J.
Price, Elizabeth
Coutré, Steven E.
Gotlib, Jason
Berube, Caroline
Kaufman, Gregory P.
Medeiros, Bruno C.
Liedtke, Michaela http://orcid.org/0000-0001-8945-5850
Clinical trials referenced in this document:
Documents that mention this clinical trial
A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma
https://doi.org/10.1007/s12185-018-2468-5
Funding for this research was provided by:
Celgene
Article History
Received: 15 February 2018
Revised: 24 April 2018
Accepted: 25 April 2018
First Online: 25 May 2018
Compliance with ethical standards
:
: Drs. Liedtke, Medeiros and Coutre have received research support funding from Celgene. The remaining authors declare no conflicts of interest, financial or otherwise.
Free to read: This content has been made available to all.